Financial Architects (New Jersey)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Financial Architects (New Jersey)’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10	Closed	–	–	1629
2018 Q1	$0	Hold	10	–	–	﹤0.01%	1716
2017 Q4	$0	Hold	10	–	–	﹤0.01%	1712
2017 Q3	$0	Hold	10	–	–	﹤0.01%	1703
2017 Q2	$0	Hold	10	–	–	﹤0.01%	1743
2017 Q1	$0	Buy	+10	New	+$46	﹤0.01%	1694
2016 Q4	–	Sell	-510	Closed	-$2K	–	1582
2016 Q3	$2K	Hold	510	–	–	﹤0.01%	1383
2016 Q2	$2K	Buy	+510	New	+$2.34K	﹤0.01%	1381

Other funds holding CTIC

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return